These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity. Maxwell DM; Koplovitz I J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881 [TBL] [Abstract][Full Text] [Related]
7. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice. Shapira S; Kadar T; Cohen G; Chapman S; Raveh L Arch Toxicol; 1990; 64(8):663-8. PubMed ID: 2090035 [TBL] [Abstract][Full Text] [Related]
8. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase. Millard CB; Lockridge O; Broomfield CA Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044 [TBL] [Abstract][Full Text] [Related]
9. Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs. Due AH; Trap HC; Van Der Wiel HJ; Benschop HP Arch Toxicol; 1993; 67(10):706-11. PubMed ID: 8135661 [TBL] [Abstract][Full Text] [Related]
10. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase. Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555 [TBL] [Abstract][Full Text] [Related]
12. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity. Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656 [TBL] [Abstract][Full Text] [Related]
13. Genetic and biochemical evidence for the lack of significant hydrolysis of soman by a Flavobacterium parathion hydrolase. Pogell BM; Rowland SS; Steinmann KE; Speedie MK; Hoskin FC Appl Environ Microbiol; 1991 Feb; 57(2):610-1. PubMed ID: 1849715 [TBL] [Abstract][Full Text] [Related]
14. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566 [TBL] [Abstract][Full Text] [Related]
15. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice. Clement JG Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compounds in mice. Ashani Y; Rothschild N; Segall Y; Levanon D; Raveh L Life Sci; 1991; 49(5):367-74. PubMed ID: 1649941 [TBL] [Abstract][Full Text] [Related]
17. The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy. Bosković B Arch Toxicol; 1979 Jul; 42(3):207-16. PubMed ID: 475595 [TBL] [Abstract][Full Text] [Related]
18. Carbamates of (hydroxyphenoxy)methyl heteroaromatic salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds. Sundberg RJ; Dalvie D; Cordero J; Sabat M; Musallam HA Chem Res Toxicol; 1993; 6(4):500-5. PubMed ID: 8374048 [TBL] [Abstract][Full Text] [Related]
19. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice. Clement JG; Benschop HP; DeJong LP; Wolthuis OL Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185 [TBL] [Abstract][Full Text] [Related]
20. Sodium pentobarbital alteration of the toxicity and distribution of soman (pinacolyl methylphosphonofluoridate) in mice. Clement JG Biochem Pharmacol; 1984 Feb; 33(4):683-5. PubMed ID: 6704186 [No Abstract] [Full Text] [Related] [Next] [New Search]